Thiomersal: implementation of the warning statement relating to sensitisation
Table of contents
This document provides guidance on the wording of the summary of product characterisitics and the package lefleat for the use of thiomersal in medicinal products with regard to sensitisation.
A 2016 review of this guideline concluded that it remains up-to-date and relevant.
Keywords: Thiomersal, preservative, vaccines, immunoglobulins, antimicrobial, organomercuric, summary of product characteristics (SmPC), sensitisation